Navigation Links
Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform
Date:12/15/2009

Prostate cancer tests promised but not delivered

WASHINGTON, Dec. 15 /PRNewswire-USNewswire/ -- Men's Health Network calls on Congress to ensure that healthcare reform does not override the prostate cancer testing benefit currently required of insurance companies in 37 states.

Prostate cancer screening is particularly important for those segments of the population and individuals who are identifiable as high risk, including African American men and men who have a family history of prostate cancer. The American Urological Association currently recommends that men age 40 consider a "baseline" prostate cancer test.

"My husband, the Late Congressman Dean Gallo, did not have the benefit of the PSA as a prostate cancer screening method in 1991. Therefore, in 1992 he was diagnosed with late stage prostate cancer. It was stage 4 and he had a PSA of 883. If the PSA test was available my husband would not have died from this disease. A complete prostate cancer exam, including the DRE and PSA, identifies cancers while they can still be treated and should be made available to all men aged 40 and above," shared Betty Gallo, Co-Founder of Women Against Prostate Cancer.

Recent changes in national guidelines for mammography screenings from the United States Preventive Services Task Force (USPSTF) have caused a flurry of discussion around the role of the Task Force. Men's Health Network has monitored their recommendations closely for many years and is concerned that the USPSTF does not recommend prostate cancer testing even while the use of the DRE and PSA continues to save lives.

A new proposal in the Senate health care debate would let people aged 55-64 buy into Medicare. If this passes, it could lead to a significant increase in the number of men who have access to prostate cancer tests through the "Welcome to Medicare" physical, offered to every person entering Medicare. And, one can only ask, why should the general population receive services inferior to those offered to Medicare recipients, such as the tests in the "Welcome to Medicare" physical?

Prostate cancer testing has been supported by a resolution of the Democratic National Committee in September 2009 and by President Obama in a town hall meeting and again in a Weekly Address on August 15. President Obama said that he would "require insurance companies to cover routine checkups and preventive care" so that "diseases like breast cancer and prostate cancer" can be detected early.

While Senator Mikulski's amendment has passed to ensure protections for women's preventive services, no such amendment is being proposed to ensure that men received the same protections for prostate or other screenings.

"We call on Congress to complete President Obama's promise to provide prostate screening in the health reform bill in addition to the breast cancer screening recently added," stated Scott Williams, VP for Men's Health Network.

Men's Health Network (www.menshealthnetwork.org), a national non-profit organization, reaches men and their families where they live, work, play, and pray.

SOURCE Men's Health Network


'/>"/>
SOURCE Men's Health Network
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lumension Webinar Discusses How to Effectively Streamline Security and Compliance Initiatives
2. New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities
3. Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE, Siemens and Toshiba Scanners
4. Siemens Healthcare Unveils syngo.plaza at RSNA 2009
5. Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via
6. Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services
7. Lumension Endpoint Management Platform Strategy to Reduce Complexity, Enhance Security & Compliance, and Expand Visibility across IT Operations and Security Functions
8. New Ponemon-Lumension Study Reveals Companies Slow to Adapt to Changing Security, Technology Environment
9. Lumension Webinar Highlights the Evolving State of the Endpoint
10. Lumension Provides Enhanced Endpoint Protection and Support for The Latest Windows Platforms
11. Lumension Announces General Availability of its Data Protection Solution for Microsoft System Center and Joins Microsoft System Center Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi and Dr. Douglas ... not do their research and undergo cosmetic dermatology treatments from unqualified practitioners or worse, ... renaissance and every other month a new treatment or device is launched, promising everlasting ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... Mentz won "Best Surgical Facial Rejuvenation" at the 2016 Anti-Aging & Beauty ... France. , The Aesthetic & Anti-aging Medicine European Congress (AMEC) brings ...
(Date:12/5/2016)... ... December 05, 2016 , ... A newly released study has ... reproducibility and accuracy of placing precordial electrodes with little cognitive effort and a ... 60 years, studies have shown that single electrode misplacement is one of the ...
(Date:12/4/2016)... NY (PRWEB) , ... December 03, 2016 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – hosted its first Swirl: A Wine Tasting Event in New York City, ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... 3, 2016 Johnson & Weaver, LLP announces that ... of Zimmer Biomet Holdings, Inc. (NYSE: ZBH ) ... 31, 2016 (the "Class Period"). Zimmer Biomet provides ... orthopaedic reconstructive products, such as knee and hip reconstructive products. ... , , ...
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)...  Results from the Phase II SUSTAIN study show ... the median annual rate of sickle cell-related pain crises ... p=0.010) in patients with or without hydroxyurea therapy 1 ... featured in the official press briefing at the 58 ... and presented during the Plenary Scientific Session tomorrow (Abstract ...
Breaking Medicine Technology: